Personalized Bio-Engineered Human Hearts: Bringing Hope for All Through the Vision of Dr. Doris A. Taylor, Ph.D., CEO, Organamet Bio Inc.

Dr. Doris A. Taylor — CEO of Organamet Bio Inc. – Personalized bio-engineered human hearts
Organamet Bio Inc. CEO Dr. Doris A. Taylor Ph.D.

Dr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet’s goal is to provide personalized bio-engineered hearts to those who need them within five years. This will increase availability and accessibility of hearts, decrease or eliminate the need for immunosuppression and reduce total lifetime transplant cost.

Dr. Taylor worked as the Director of Regenerative Medicine and the Director of the Center for Cell and Organ Biotechnology at the Texas Heart Institute, Houston, Texas. She focused on integrating regenerative medicine and tissues engineering.

Dr. Taylor holds a Ph.D. from the UT Southwestern Medical Center in Dallas, Texas. She completed her postdoctoral training at Albert Einstein College of Medicine, in Bronx (New York), where she worked first with tissue engineering and grew heart muscle cells in a laboratory.

Dr. Taylor was on the faculty of Duke University from 1991 to 2007, and then moved to University of Minnesota, where in 2008 her team published a landmark paper in Nature Medicine where they created new beating rat hearts using a combination of tissue engineering processes, first stripping the dead dying cells away from an existing heart (in a process called \”de-cellularization\”) leaving behind the hearts extracellular matrix and then re-seeding the matrix by injecting new young rat stem cells.

Dr. Taylor was also a co-founder and founding member of Miromatrix Medical Inc.

Dr. Taylor has published her work in Nature Medicine and Circulation Research as well as The Journal of Molecular Biology The Journal of Biochemistry Journal of the American College of Cardiology Journal of the American Medical Association Journal of Biochemistry Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Society Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Association Journal of the American Medical Journal She is the inventor of a number invention disclosures, applications for patents and patents. She also founded multiple companies that focus on cardiovascular repair technologies. She is a part of the Society for Women’s Health Research’s Cardiovascular Working Group (SWHR), and the Organization for the Study of Sex Differences. She is also affiliated with the American Association for the Advancement of Science, the American Heart Association and the Federation of American Societies for Experimental Biology. She served recently on the Executive Committee for Alliance for Regenerative Medicine.

The AHA has recognized Dr. Taylor for Top 10 Research Advances. Her work was featured on 60 Minutes and by NPR, CNN and other media outlets.

Source:

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注